Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology | Musculoskeletal
Disease Category: Leukemia
Location: United States, WV
Clinical Trial Details
Research Study Summary
E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)
Objective is to evaluate the effect of clofarabine induction and consolidation therapy on overall survival in comparison with standard therapy (daunorubicin & cytarabine) in newly diagnosed AML patients age 60+.
To Learn more
Both Male and Female
Date Last Changed:
July 22, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.